OTC · Healthcare
SCIENTIFIC INDUSTRIES INC (SCND)
As-reported financials and recent SEC filings for SCIENTIFIC INDUSTRIES INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.1M
Net income
$-1.2M
Net margin
-24.1%
Diluted EPS
$-0.11
ROE
-11.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.1M | $4.8M | $11.1M | $11.4M | $9.8M |
| Gross profit | $1.3M | $2.0M | $5.1M | $5.7M | $5.0M |
| Operating income | $-7.9M | $-8.2M | $-9.3M | $-11.5M | $-4.7M |
| Net income | $-1.2M | $-6.4M | $-9.1M | $-13.7M | $-3.7M |
| Diluted EPS | $-0.11 | $-0.61 | $-1.27 | — | $-0.50 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-18
View on EDGAR →10-Q2026-05-15
View on EDGAR →42026-04-01
View on EDGAR →42026-04-01
View on EDGAR →10-K2026-03-31
View on EDGAR →42026-03-24
View on EDGAR →42026-03-17
View on EDGAR →42026-03-17
View on EDGAR →Largest Healthcare peers
Go deeper on SCND
Search SCIENTIFIC INDUSTRIES INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.